Immuneering Competitors and Similar CompaniesClear all
Immuneering's competitors and similar companies include Signpath Pharma, ImmunoMet and Immodulon Therapeutics.
 Immuneering Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases. |  Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia. |  ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Immodulon Therapeutics Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer. | |
Founding Date | Founding Date 2008 | Founding Date 2006 | Founding Date 2015 | Founding Date N/A |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Cambridge, US HQ New York, US San Diego, US | Locations Sandy, US HQ | Locations Houston, US HQ | Locations Hayes, GB HQ London, GB |
Employees | Employees 5320% decrease | Employees 11 | Employees 814% increase | Employees 10 |
Funding | ||||
Total funding raised | Total funding raised $ 57.2m | Total funding raised $ 5.3m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Signpath Pharma
HQ
Sandy, US
Employees
11
SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
View companyImmunoMet
HQ
Houston, US
Employees
8↑ 14% increase
ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism.
View companyImmodulon Therapeutics
HQ
Hayes, GB
Employees
10
Immodulon Therapeutics is an immuno-oncology company focused on the development of treatments for cancer.
View company